CoChat

Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain

Open access
Yang, Jung Hoon, Wada, Akira, Yoshida, Kazuyuki, Miyoshi, Yurika, Sayano, Tomoko, Esaki, Kayoko, Kinoshita, Masami O., Tomonaga, Shozo, Azuma, Norihiro, Watanabe, Masahiko, Hamase, Kenji, Zaitsu, Kiyoshi, Machida, Takeo, Messing, Albee, Itohara, Shigeyoshi, Hirabayashi, Yoshio, Furuya, Shigeki · 2010 · Journal of Biological Chemistry
Cited by 146

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

In mammalian brain, D-serine is synthesized from L-serine by serine racemase, and it functions as an obligatory co-agonist at the glycine modulatory site of N-methyl-D-aspartate (NMDA)-selective glutamate receptors. Although diminution in D-serine level has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia, the source of the precursor L-serine and its role in D-serine metabolism in adult brain have yet to be determined. We investigated whether L-serine synthesized in brain via the phosphorylated pathway is essential for D-serine synthesis by generating mice with a conditional deletion of D-3-phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95). This enzyme catalyzes the first step in L-serine synthesis via the phosphorylated pathway. HPLC analysis of serine enantiomers demonstrated that both L- and D-serine levels were markedly decreased in the cerebral cortex and hippocampus of conditional knock-out mice, whereas the serine deficiency did not alter protein expression levels of serine racemase and NMDA receptor subunits in these regions. The present study provides definitive proof that L-serine-synthesized endogenously via the phosphorylated pathway is a key rate-limiting factor for maintaining steady-state levels of D-serine in adult brain. Furthermore, NMDA-evoked transcription of Arc, an immediate early gene, was diminished in the hippocampus of conditional knock-out mice. Thus, this study demonstrates that in mature neuronal circuits L-serine availability determines the rate of D-serine synthesis in the forebrain and controls NMDA receptor function at least in the hippocampus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m110.187443

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 56

  1. Scheetz, 1994, FASEB J., 8, 745, 10.1096/fasebj.8.10.8050674 · DOI · Paper page
  2. Johnson, 1987, Nature., 325, 529, 10.1038/325529a0 · DOI · Paper page
  3. Kleckner, 1988, Science., 241, 835, 10.1126/science.2841759 · DOI · Paper page
  4. Danysz, 1998, Pharmacol. Rev., 50, 597, 10.1016/S0031-6997(24)01382-6 · DOI · Paper page
  5. Hashimoto, 1992, FEBS Lett., 296, 33, 10.1016/0014-5793(92)80397-Y · DOI · Paper page
  6. Hashimoto, 1997, Prog. Neurobiol., 52, 325, 10.1016/S0301-0082(97)00019-1 · DOI · Paper page
  7. Boehning, 2003, Annu. Rev. Neurosci., 26, 105, 10.1146/annurev.neuro.26.041002.131047 · DOI · Paper page
  8. Nishikawa, 2005, Biol. Pharm. Bull., 28, 1561, 10.1248/bpb.28.1561 · DOI
  9. Wolosker, 2008, FEBS J., 275, 3514, 10.1111/j.1742-4658.2008.06515.x · DOI · Paper page
  10. Hashimoto, 1993, J. Neurochem., 60, 783, 10.1111/j.1471-4159.1993.tb03219.x · DOI · Paper page
  11. Matsui, 1995, J. Neurochem., 65, 454, 10.1046/j.1471-4159.1995.65010454.x · DOI · Paper page
  12. Mothet, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 4926, 10.1073/pnas.97.9.4926 · DOI · Paper page
  13. Panatier, 2006, Cell., 125, 775, 10.1016/j.cell.2006.02.051 · DOI · Paper page
  14. Wood, 1989, J. Neurochem., 53, 979, 10.1111/j.1471-4159.1989.tb11803.x · DOI
  15. Contreras, 1990, Neuropharmacology., 29, 291, 10.1016/0028-3908(90)90015-J · DOI
  16. Tanii, 1994, J. Pharmacol. Exp. Ther., 269, 1040, 10.1016/S0022-3565(25)38840-3 · DOI
  17. Tsai, 1998, Biol. Psychiatry., 44, 1081, 10.1016/S0006-3223(98)00279-0 · DOI · Paper page
  18. Heresco-Levy, 2005, Biol. Psychiatry., 57, 577, 10.1016/j.biopsych.2004.12.037 · DOI · Paper page
  19. Javitt, 2004, Mol. Psychiatry., 9, 984, 10.1038/sj.mp.4001551 · DOI · Paper page
  20. Wolosker, 1999, Proc. Natl. Acad. Sci. U.S.A., 96, 721, 10.1073/pnas.96.2.721 · DOI · Paper page
  21. Cook, 2002, J. Biol. Chem., 277, 27782, 10.1074/jbc.M111814200 · DOI
  22. De Miranda, 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 14542, 10.1073/pnas.222421299 · DOI · Paper page
  23. Neidle, 2002, Neurochem. Res., 27, 1719, 10.1023/A:1021607715824 · DOI
  24. Strísovský, 2003, FEBS Lett., 535, 44, 10.1016/S0014-5793(02)03855-3 · DOI
  25. Foltyn, 2005, J. Biol. Chem., 280, 1754, 10.1074/jbc.M405726200 · DOI · Paper page
  26. Dunlop, 1997, Biochem. Biophys. Res. Commun., 235, 26, 10.1006/bbrc.1997.6724 · DOI
  27. Inoue, 2008, J. Neurosci., 28, 14486, 10.1523/JNEUROSCI.5034-08.2008 · DOI · Paper page
  28. Basu, 2009, Mol. Psychiatry., 14, 719, 10.1038/mp.2008.130 · DOI · Paper page
  29. Labrie, 2009, Hum Mol. Genet., 18, 3227, 10.1093/hmg/ddp261 · DOI · Paper page
  30. Hirabayashi, 2008, Prog. Lipid Res., 47, 188, 10.1016/j.plipres.2008.01.003 · DOI
  31. Furuya, 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 11528, 10.1073/pnas.200364497 · DOI · Paper page
  32. Yamasaki, 2001, J. Neurosci., 21, 7691, 10.1523/JNEUROSCI.21-19-07691.2001 · DOI · Paper page
  33. de Koning, 2006, J. Inherit. Metab. Dis., 29, 347, 10.1007/s10545-006-0269-0 · DOI
  34. Fuchs, 2006, Ann. Neurol., 60, 476, 10.1002/ana.20977 · DOI
  35. Zhuo, 2001, Genesis., 31, 85, 10.1002/gene.10008 · DOI · Paper page
  36. Holzenberger, 2000, Nucleic. Acids Res., 28, E92, 10.1093/nar/28.21.e92 · DOI · Paper page
  37. Furuya, 2008, Funct. Integr. Genomics., 8, 235, 10.1007/s10142-007-0072-5 · DOI
  38. Kawakami, 2009, Neurosci. Res., 63, 184, 10.1016/j.neures.2008.12.002 · DOI
  39. Morikawa, 2003, Anal. Biochem., 312, 66, 10.1016/S0003-2697(02)00432-3 · DOI
  40. Abe, 2004, J. Neurosci., 24, 7292, 10.1523/JNEUROSCI.1261-04.2004 · DOI · Paper page
  41. Watanabe, 1998, Eur. J. Neurosci., 10, 478, 10.1046/j.1460-9568.1998.00063.x · DOI · Paper page
  42. Menniti, 2000, Neuropharmacology., 39, 1147, 10.1016/S0028-3908(99)00211-7 · DOI
  43. Cho, 2000, Gene., 245, 193, 10.1016/S0378-1119(00)00009-3 · DOI
  44. Klomp, 2000, Am. J. Hum. Genet., 67, 1389, 10.1086/316886 · DOI
  45. Takasaki, 2007, Biomed. Res., 28, 61, 10.2220/biomedres.28.61 · DOI
  46. Kartvelishvily, 2006, J. Biol. Chem., 281, 14151, 10.1074/jbc.M512927200 · DOI · Paper page
  47. Miya, 2008, J. Comp. Neurol., 510, 641, 10.1002/cne.21822 · DOI · Paper page
  48. Link, 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 5734, 10.1073/pnas.92.12.5734 · DOI · Paper page
  49. Lyford, 1995, Neuron., 14, 433, 10.1016/0896-6273(95)90299-6 · DOI · Paper page
  50. Coba, 2008, J. Biol. Chem., 283, 34101, 10.1074/jbc.M804951200 · DOI · Paper page
  51. Mitoma, 1998, Neurosci. Res., 30, 195, 10.1016/S0168-0102(97)00113-2 · DOI
  52. Yoshikawa, 2008, J. Pharmacol. Sci., 107, 270, 10.1254/jphs.08030FP · DOI
  53. Mustafa, 2010, J. Neurosci., 30, 1413, 10.1523/JNEUROSCI.4297-09.2010 · DOI
  54. Oldendorf, 1971, Am. J. Physiol., 221, 1629, 10.1152/ajplegacy.1971.221.6.1629 · DOI · Paper page
  55. Smith, 1987, J. Neurochem., 49, 1651, 10.1111/j.1471-4159.1987.tb01039.x · DOI · Paper page
  56. Bendikov, 2007, Schizophr. Res., 90, 41, 10.1016/j.schres.2006.10.010 · DOI · Paper page

Cited by

See all 146

Metadata

Authors
Yang, J. H., Wada, A., Yoshida, K., Miyoshi, Y., Sayano, T., Esaki, K., Kinoshita, M. O., Tomonaga, S., Azuma, N., Watanabe, M., Hamase, K., Zaitsu, K., Machida, T., Messing, A., Itohara, S., Hirabayashi, Y., & Furuya, S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2010-12
Volume
285
Issue
53
Pages
41380-41390
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2149932734
Cited by
146
References
6
FWCI
3.65
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.